A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma
- Conditions
- T-Lymphoblastic Lymphoma/Leukemia
- Registration Number
- NCT04320992
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
The purpose of this study is to determine the indicative value of "high risk" molecular typing in patients with adult T lymphoblastic lymphoma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 207
Inclusion Criteria
- biopsy proved T lymphoblastic lymphoma
- newly diagnosed patients
Exclusion Criteria
- patients with biopsy samples unavailable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression free survival 3-years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms define high-risk subtypes in adult T lymphoblastic lymphoma according to NCT04320992?
How does molecular typing in NCT04320992 compare to standard-of-care risk stratification for T-ALL patients?
Which biomarkers identified in NCT04320992 correlate with poor prognosis in T lymphoblastic lymphoma?
What adverse events are associated with high-risk molecular profiles in T-ALL and how are they managed?
Are there targeted therapies or drug combinations under investigation for high-risk T lymphoblastic lymphoma subtypes identified in NCT04320992?
Trial Locations
- Locations (1)
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University,
🇨🇳Guangzhou, China
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University,🇨🇳Guangzhou, ChinaZhihua Li, PhDContact